Brown Financial Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$951K Sell
15,142
-1,676
-10% -$117K 0.36% 83
2025
Q4
$1.12M Buy
16,818
+1,312
+8% +$84.8K 0.41% 78
2025
Q3
$1.04M Buy
15,506
+613
+4% +$48.5K 0.39% 84
2025
Q2
$1.3M Sell
14,893
-1,254
-8% -$98.3K 0.51% 72
2025
Q1
$1.1M Buy
16,147
+1,515
+10% +$124K 0.45% 80
2024
Q4
$1.14M Buy
14,632
+3,839
+36% +$284K 0.46% 69
2024
Q3
$724K Sell
10,793
-109
-1% -$8.95K 0.3% 90
2024
Q2
$1.24M Buy
+10,902
New +$1.38M 0.55% 63

Other funds holding DXCM

Brown Financial Advisors's DXCM Position: Q1 2026 in Review

Brown Financial Advisors reduced its DexCom (DXCM) stake by 10% in Q1 2026, selling an estimated $117K and leaving 15,142 shares worth $951K. The position accounts for 0.36% of the portfolio, ranked #83.

Brown Financial Advisors first reported a position in DXCM in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.3M in Q2 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Brown Financial Advisors held 15,142 shares of DexCom worth $951K as of Q1 2026.
  • Brown Financial Advisors sold 1,676 DexCom shares in Q1 2026, an estimated $117K.
  • DexCom made up 0.36% of Brown Financial Advisors's portfolio in Q1 2026, its #83 holding.
  • Brown Financial Advisors first reported a position in DexCom in Q2 2024 and has held it in 8 quarters since.
  • Brown Financial Advisors's DexCom position peaked at $1.3M in Q2 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Brown Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.